Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X

Journal Article · · Nat. Commun.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1839734
Journal Information:
Nat. Commun., Vol. 12
Country of Publication:
United States
Language:
ENGLISH

References (35)

Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees May 2021
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies March 2021
Neutralizing Activity of BNT162b2-Elicited Serum April 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 March 2021
Relief and worry for immune-suppressed people April 2021
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients May 2021
A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks March 1995
Crystal Structure of a Shark Single-Domain Antibody V Region in Complex with Lysozyme September 2004
Maturation of Shark Single-domain (IgNAR) Antibodies: Evidence for Induced-fit Binding March 2007
An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model March 2019
Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability October 2018
Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development December 2017
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies June 2020
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor October 2013
Origin and evolution of pathogenic coronaviruses December 2018
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4 July 2013
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies October 2020
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients June 2021
SARS‐CoV‐2 neutralization and serology testing of COVID‐19 convalescent plasma from donors with nonsevere disease October 2020
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV April 2020
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient July 2020
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells July 2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike July 2020
The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates August 2021
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity November 1995
Vpr Is Required for Efficient Replication of Human Immunodeficiency Virus Type-1 in Mononuclear Phagocytes February 1995
Structural basis of receptor recognition by SARS-CoV-2 March 2020
COVID-19-neutralizing antibodies predict disease severity and survival January 2021
Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression September 2005
Essential requirement for JPT2 in NAADP-evoked Ca 2+ signaling March 2021
An Infectious cDNA Clone of SARS-CoV-2 May 2020
XDS January 2010
Phaser crystallographic software July 2007
Features and development of Coot March 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution January 2010